Xcout Intel
CIRCIO HOLDING competitors & alternatives
The 12 closest competitors and alternatives to CIRCIO HOLDING among biotech companies — ranked by similarity to what CIRCIO HOLDING actually does, not by market-cap band.
Subscribe to see CIRCIO HOLDING’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CIRCIO HOLDING
Circio Holding ASA is a biotechnology company that develops novel circular RNA and immunotherapy medicines, utilizing its proprietary circVec platform to enhance gene therapy for genetic diseases. It serves the biopharmaceutical sector and patients with genetic disorders by advancing clinical programs and engaging in research collaborations.
CIRCIO HOLDING at a glance
CIRCIO HOLDING is a biotech company headquartered in Norway. Xcout tracks 4 named people at CIRCIO HOLDING, including Damian Marron (Chairman of the Board).
CIRCIO HOLDING leadership
- Damian MarronChairman of the Board
- Diane MellettBoard member
- Robert BurnsDeputy Board member
- Thomas FalckBoard member
Top 12 CIRCIO HOLDING competitors
Ranked by semantic similarity — how close each company is to CIRCIO HOLDING by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Scenic Biotech is a biotechnology company headquartered in Amsterdam, Netherlands, that advances modifier therapy as an approach to treating genetic disorders by uncovering novel genome pathways.
Similar biotech company
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotechnology
Skip Therapeutics is an Israeli biotechnology company founded in 2021 and based in Ness Ziona. The company develops personalized RNA-based therapies, including antisense oligonucleotides, for rare genetic disorders and common diseases using a proprietary computational discovery engine.
Healthcare
Dicerna Pharmaceuticals was a biotechnology company that developed RNA interference (RNAi) therapeutics using its proprietary GalXC platform. It focused on medicines for patients with rare, chronic liver, cardiovascular, and metabolic diseases, and was acquired by Novo Nordisk in 2021.
Biotechnology
Aro Biotherapeutics is a U.S. biotechnology company developing targeted therapeutics using its Centyrin protein platform, including delivery of genetic medicines to specific tissues and cells. It serves patients with serious diseases and partners or works with biopharmaceutical organizations to advance targeted drug-development programs.
Similar biotech company
AAVantgarde Bio is an Italian biotechnology company developing adeno-associated virus (AAV) gene therapies for rare genetic diseases, including conditions caused by genes too large to fit into a single AAV vector. Its technology uses dual-AAV approaches to deliver larger therapeutic genes, serving patients with serious inherited disorders and the clinicians who treat them.
Similar biotech company
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Similar biotech company
Centogene provides precision medicine solutions through advanced diagnostics, multiomic testing, and bioinformatics platforms. The company serves physicians, patients, and pharmaceutical partners by offering genomic sequencing, biomarker testing, and data-driven insights to accelerate rare disease diagnosis, drug discovery, and personalized therapies.
Biotechnology
RNAV8 Bio is a biotechnology research company focused on renovating mRNA function through structure, chemistry, and delivery.
Biotechnology
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Biotechnology
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Biotechnology
Irazú Bio partners with academic researchers and university centers to curate and advance translational research assets into IND-enabling studies and Phase 1 clinical trials. The company focuses on areas such as hypoxia tolerance, antiviral formulations, and adeno-associated virus gene therapy, subsequently licensing the developed assets to pharmaceutical companies or forming new ventures with venture capital groups.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CIRCIO HOLDING and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CIRCIO HOLDINGand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →